UNSPSC 51263306: Dioxadilol

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51263306

Definition

This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H25NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G25Z4785LV, chemically known as (- )-1-(1,4-benzodioxan-2-ylmethoxy)-3-(tert-butylamino)-2-propanol. but generally known as dioxadilol, which bears US NIH Compound Identifier 208844. European Medicines Agency schedules Dioxadilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07199MIG.

Read the full definition

The term DIOXADILOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). DIOXADILOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dioxadilol under HS 29329985 and SITC 51569. As of Q4 2014, DIOXADILOL remains the US FDA Preferred Term for this commodity. Dioxadilol bears US NLM identifiers UMLS ID C1880338 and NCI Concept Code C65414. SMILES: O(CC(O)CNC(C)(C)C)CC1OC2C(OC1)CCCC2.

About UNSPSC 51263306

UNSPSC 51263306 Dioxadilol is a Commodity code that encompasses pharmaceutical chemical products used in medical and public health applications, though recent state and local procurement activity under this code shows limited and potentially misaligned usage. The single recent opportunity on record involves Seminole County, Florida's procurement of naloxone and safe drug deactivation systems through an IFB (Invitation for Bid) — products that fall outside the nominal scope of dioxadilol, a specific pharmaceutical compound. This mismatch suggests that either the code has been applied inconsistently in state and local procurement systems, or the code sees minimal relevant solicitation activity aligned with its true product definition. State and local buyers posting under this code appear to include county-level health and community services departments, though the available record does not support broader characterization of issuing-body types or repeat buyers.

Geographic activity is concentrated in Florida based on the single recent opportunity. Seminole County issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. The contract carries a two-year initial term with an optional one-year renewal, fixed-fee pricing structure, and standard compliance requirements including drug-free workplace certification and E-Verify. The procurement does not designate set-asides for disadvantaged enterprises. The limited recent-opportunity record and the apparent misalignment between the code name and actual procurement activity suggest this Commodity code warrants close monitoring for reclassification or clarification before pursuing opportunities under it.

Quick answers

What is UNSPSC 51263306?

UNSPSC 51263306 is Dioxadilol, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51263306?

UNSPSC 51263306 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51263306

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code